Background: Despite that the epidemiological studies on the comorbidity of alcohol misuse and psychiatric disorders have been studied, less is known about the magnitude of these disorders among patients with alcoholic liver disease (ALD). Our aim was to determine the prevalence of psychiatric and substance use disorders among hospitalized ALD patients in the United States.
XCESSIVE ALCOHOL CONSUMPTION can cause diseases with significant economic and social burdens (Basra and Anand, 2011; Rehm et al., 2013) . Recent data showed that approximately 6% of all global deaths were attributed to alcohol consumption (World Health Organization, 2015) . Alcoholic liver disease (ALD) is a main cause of alcohol-related morbidity accounting for 48% of all deaths from cirrhosis (Rehm et al., 2013) . It consists of a spectrum of disorders ranging from alcohol-induced fatty liver to alcoholic hepatitis and cirrhosis. Alcoholic steatosis, once considered benign, is now recognized as a condition that may lead to advanced liver disease or cirrhosis (Teli et al., 1995) . At present, there are no specific pharmacotherapies for patients with ALD. In those with advanced and decompensated liver disease, liver transplantation has been shown to improve the overall outcomes and survival (Mathurin and Bataller, 2015; Varma et al., 2011) . Abstaining from alcohol is the cornerstone in the management of ALD. A French study showed the improvement in Child-Pugh scores in 66% of subjects with ALD who became abstinent (Veldt et al., 2002) .
One of the major problems in the management of patients with ALD is the relapse to harmful drinking after abstinence (Cuadrado et al., 2005; Egawa et al., 2014) . Alcohol use relapse is a risk factor for hepatic decompensation and recurrent alcoholic hepatitis (Potts et al., 2013) . In postliver transplant patients, it can lead to poor compliance to medical care, graft loss, and impaired long-term survival (Cuadrado et al., 2005; Egawa et al., 2014; Hartl et al., 2011; Pfitzmann et al., 2007) . Several factors predicting relapse include a family history of alcohol abuse/dependence, lack of self-perception of having an alcohol drinking problem, a poor social support system, the duration of abstinence before liver transplantation, and underlying psychological disorders (other than alcohol abuse/dependence; Dew et al., 2008; Egawa et al., 2014; Hartl et al., 2011) .
Previous reports have shown that those with alcohol misuse/dependence are more likely to have other psychiatric conditions such as major depressive disorder, generalized anxiety disorder, and posttraumatic stress disorder compared to those without alcohol dependence (Kessler et al., 1996; Petrakis et al., 2002; Regier et al., 1990) . Although psychological as well as pharmacological therapies for psychiatric disorders and alcohol use disorders can be offered to assist these patients, they frequently do not receive treatment(s) addressing both conditions (Petrakis et al., 2002) . Despite epidemiological studies on the comorbidity of alcohol misuse and psychiatric disorders (Kessler et al., 1996; Petrakis et al., 2002; Regier et al., 1990) , less is known about the prevalence of psychiatric disorders among patients with ALD. Understanding the scope of these problems among ALD patients is essential to develop comprehensive plans that address both alcohol and psychiatric disorders. The objective of our study was to determine the co-occurrence of psychiatric disorders among hospitalized ALD patients in the United States.
MATERIALS AND METHODS

Data Source
The National Inpatient Sample (NIS) 2011 data were used for the analyses. The NIS is the largest publicly available all-payer inpatient healthcare database, which was collected as part of the Healthcare Cost and Utilization Project (HCUP) by the Agency for Healthcare Research and Quality (HCUP Databases, 2017) . The data contain 8 million hospital stays from about 1,000 hospitals sampled to approximate a 20% stratified sample of U.S. community hospitals. In the NIS data, the U.S. community hospitals are divided into strata using 5 hospital characteristics: ownership/control, bed size, teaching status, urban/rural location, and U.S. region. The sampling probabilities are proportional to the number of U.S. community hospitals in each stratum. Weights were provided to calculate national estimates. Sampling of hospitals and sample weights of the NIS data are described elsewhere (HCUP Databases, 2017) .
Study Cohort and Variables Identification
We identified 3 cohorts from the NIS 2011 data using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM; Centers for Disease Control and Prevention, 2015) . The first cohort was patients with alcoholic hepatitis/cirrhosis and those with the diagnosis of alcohol-related disorder (as defined by ICD-9-CM codes in Table S1 ) who presented with elevated liver enzymes in the absence of other liver etiologies such as viral hepatitis, biliary cirrhosis, autoimmune liver disease, nonalcoholic cirrhosis, etc. The second cohort was hospitalized patients with other chronic liver diseases (such as nonalcoholic steatohepatitis, hepatitis C infection, and biliary cirrhosis) not caused by alcohol. Any patients who had the diagnosis of alcohol dependence syndrome, nondependent alcohol abuse, and toxic effect of alcohol were excluded. For the last cohort, we randomly selected 5% of all hospitalized subjects with no known liver diseases. We used the single-level clinical classification software category to identify subjects with psychiatric and nonalcohol-related substance use disorders. This software provides collapsed clinically meaningful categories of over 14,000 diagnostic codes as well as 3,900 procedural codes. The ICD-9-CM codes used in our study are provided in Table S1 .
Statistical Analyses
All statistical analyses were performed using SAS 9.3 software (Cary, NC) accounting for the sampling weights and stratified sample design of the NIS data to attain nationally representative estimates (HCUP Databases, 2017) . Basic descriptive statistics such as mean and standard deviation (for continuous variables) and percentages (for categorical variables) were used to describe the study cohorts.
The primary outcome of interest was the prevalence of psychiatric/mental disorders in hospitalized patients among the 3 cohorts. Chi-square (v 2 ) analyses were used to compare the differences in the prevalence between/among groups. Logistic regression analyses adjusting for potential covariates such as age, sex, race, and income quartile were used to determine the independent predictors of psychiatric/mental disorders. All the analyses were 2-tailed. The p-value less than 0.05 was considered statistically significant.
RESULTS
Demographic Characteristics of the Study Cohorts
The detailed characteristics of the study cohorts are summarized in Table 1 . Patients with ALD were younger (53.3 AE 0.2 years) than those with chronic liver diseases not caused by alcohol (58.8 AE 0.4 years) and those without underlying liver diseases (57.6 AE 0.4 years). Among patients with ALD, most were men (71%) and White (69%). While Medicare was the primary payer (~45%) for patients with chronic liver disease not caused by alcohol, only 29% of patients with ALD were covered by Medicare (p < 0.001).
Prevalence of Psychiatric/Nonalcohol-Related Substance Use Disorders Among Study Cohorts
The prevalence of adjustment disorder (0.58 vs. 0.42), anxiety disorder (8.84 vs. 7.54), mood disorders (24.3 vs. 18.8), personality disorder (0.96 vs. 0.73), nonalcohol-related substance abuse (12.4 vs. 9.9), suicide-related disorder (2.4 vs. 1.1), tobacco use (43.8 vs. 27.9), posttraumatic stress disorder (1.14 vs. 0.82), and depression (3.9 vs. 2.1) was significantly higher among hospitalized patients with ALD when compared to those with chronic liver diseases not caused by alcohol (all with respective p-value <0.05) ( Table 2 ). The prevalence of attention deficit disorder (0.54 vs. 0.43), delirium disorder (7.11 vs. 2.91), developmental disorder (0.8 vs. 0.5), impulse disorder (0.12 vs. 0.03), personality disorder (1.28 vs. 0.96), and schizo/psychotic disorder (3.44 vs. 2.35) was significantly higher in hospitalized ALD patients when compared to those without underlying liver diseases (Table 2) . Given the high prevalence of hepatitis C infection among patients with ALD, we also performed a separate analysis including patients with combination of ALD and hepatitis C infection, compared to those with chronic liver diseases not caused by alcohol. The results are shown in Table S2 .
Evaluation of the Relationship Between ALD and Psychiatric/ Nonalcohol-Related Substance Abuse Disorders by Multivariate Logistic Regression
We next assessed the association between psychiatric/nonalcohol-related substance use disorders in patients with the diagnosis of ALD compared to those with chronic liver diseases not caused by alcohol, those without underlying liver diseases using multivariate logistic regression models adjusting for potential covariates including age, sex, race, and income quartile (Table 3) . Patients with ALD were 1.16, 1.37, 1.83, 1.76, 1.72, and 1.17 times more likely to have anxiety disorder, mood disorder, depression, suicide-related disorder, tobacco use, and posttraumatic stress disorder compared to those with chronic liver diseases not caused by alcohol (Table 3 ). Similar findings were found when we compared patients with ALD and those without underlying liver diseases, except that those without underlying liver diseases had less risk for suicide-related disorders (OR 0.81) when compared to those with ALD (Table 3) .
Predictors of Psychiatric/Nonalcohol-Related Substance Use Disorders Among Hospitalized Patients with ALD
We next determined the predictors of psychiatric/nonalcohol substance use disorders among hospitalized patients with ALD (Table 4) . There was an inverse association between Women had a significantly higher risk for psychiatric/nonalcohol-related substance use disorders than men (aOR 1.58, 95% CI 1.51 to 1.66). We did not observe the levels of income as an independent predictor for these disorders.
DISCUSSION
In our present study, we aimed to determine the magnitude of psychiatric and nonalcohol-related substance use disorders among patients with ALD. The major findings of our study are as follows: (i) hospitalized ALD patients had significantly higher prevalence of several psychiatric and substance use disorders when compared to those with chronic liver diseases not caused by alcohol and those without underlying liver diseases, and (ii) the presence of these disorders is most commonly seen in young Caucasian females with ALD. Using hospitalized patients without liver diseases as reference. Co-occurrence of psychiatric illnesses is not uncommon in patients with alcohol use disorder (Helzer and Pryzbeck, 1988; Kessler et al., 1996; Regier et al., 1990) . In a large epidemiologic study in the United States, underlying psychiatric disorders, notably antisocial personality, affective, and anxiety disorders, were found in 37% among patients with alcohol use disorders (Regier et al., 1990) . While the association between alcohol use and psychiatric disorders is well described (Kessler et al., 1996; Regier et al., 1990) , less is known about the prevalence of psychiatric and substance use disorders in patients with ALD. We found a higher prevalence of several psychiatric and substance use disorders among hospitalized patients with ALD. Our results have several clinical implications. ALD patients seldom volunteer specific information or problems about their underlying drinking or psychiatric issues, unless they are asked (Helzer and Pryzbeck, 1988) ; however, even if they do, these patients may be in denial or trying to minimize the magnitude of the problems. Our data suggest that screening for underlying psychiatric disorders should be implemented as part of routine clinical cares of patients with ALD. Achieving long-term abstinence is the cornerstone of management for patients with ALD. If underlying psychiatric illnesses are undiagnosed, these patients will not receive appropriate treatment and likely relapse to alcohol use as a means of coping (Cuadrado et al., 2005; Hartl et al., 2011) . Therefore, it is crucial for hepatologists to gather comprehensive mental health information when assessing patients with ALD. Specific inquiries focusing not only on the quantity and patterns of alcohol use but also on screening questions to evaluate for possible co-occurrence of underlying psychiatric disorders are needed and should be part of routine hepatology practice. Those with positive screens should be further evaluated for definitive diagnosis and treatment. Our results also provide certain patient characteristics (i.e., younger age, Caucasians, and female patients) which are independently associated with psychiatric and substance use disorders among patients with ALD. Special focus with extensive screening may be needed when we encounter patients with ALD having these characteristics to uncover possible underlying psychiatric issues.
The strengths of our study are the careful selection of the study cohort and its large sample size representing hospitalized patients in the United States. However, our study also has several limitations. First, the prevalence of psychiatric disorders in our study is limited to those who were hospitalized. Further, the NIS data do not capture hospitalizations from Veterans Affairs hospital, short-term rehabilitation hospitals, long-term nonacute care hospitals, psychiatric hospitals, and alcoholism/chemical dependency treatment centers. There is also a possibility of underreporting of psychiatric and substance use disorders in our study cohorts. Therefore, our results may be different if the study were performed in an outpatient-based or in specialized institutes. Second, laboratory tests are not available in the NIS data so we are not able to determine the severity of underlying ALD and its contribution to our findings. Third, each NIS data entry is equivalent to 1 hospitalization. It is plausible that 1 patient may contribute to multiple entries if he/she was rehospitalized within the study period. Fourth, there is a possibility of misclassification of the study subjects when we used ICD-9-CM coding to identify our study cohorts and underlying psychiatric and substance use disorders.
In conclusion, we found significantly higher prevalence of several psychiatric and substance use disorders among hospitalized patients with ALD when compared to those with chronic liver diseases not caused by alcohol and those without underlying liver diseases. Screening and appropriate intervention should be implemented as part of routine clinical care for these patients.
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